Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
01/2009
01/27/2009US7482044 dielectrically positive liquid crystalline media comprising a dielectrically positive component, component A, comprising a dielectrically positive compound of formula I, and optionally a second dielectrically positive component, component B, comprising one or more dielectrically positive compounds
01/27/2009CA2346796C Benzoylcyclohexanediones, process for their preparation and their use as herbicides and plant growth regulators
01/22/2009US20090023913 Glucopyranosyl-substituted phenyl derivates, medicaments containing such compounds, their use and process for their manufacture
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/21/2009EP2017267A1 Synthesis of statins
01/21/2009EP1501791B1 Amino acid analogues
01/21/2009EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
01/21/2009CN101348477A Novel pravastatin lactone crystal form
01/21/2009CN101348476A Method for preparing 4,5,6,7-tetrahydromevastatin and sodium salt thereof, and solid crystallization way
01/21/2009CN101348475A Novel method for synthesizing orlistat, intermediate compound and preparation thereof
01/20/2009CA2325526C Aryl phenyl substituted cyclic ketoenols
01/15/2009WO2009007015A1 Malonamide derivatives with antithrombotic activity
01/15/2009WO2008119810A3 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof
01/15/2009WO2008101914A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
01/15/2009US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use
01/15/2009US20090018116 Therapeutic Compounds
01/15/2009CA2693396A1 Malonamide derivatives with antithrombotic activity
01/14/2009EP2013195A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials.
01/14/2009CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
01/13/2009CA2287907C Novel orally active iron (iii) chelators
01/08/2009US20090012153 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
01/08/2009US20090010860 used for protecting human hair and skin against the damaging effect of ultraviolet radiation
01/08/2009CA2690229A1 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
01/07/2009EP2010510A1 Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
01/07/2009CN100448862C Processing method for mother liquid in maltol production and device thereof
01/06/2009US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/2008
12/31/2008EP2007746A1 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
12/31/2008EP1276741B1 Phenyl substituted 4-hydroxy tetrahydropyridone and its use as pesticide and herbicide
12/30/2008US7470798 7,8-bicycloalkyl-chroman derivatives
12/25/2008US20080319211 Process for the preparation of epothilones
12/25/2008US20080319049 Compounds For the Treatment of Metabolic Disorders
12/24/2008WO2008156817A2 Renin inhibitors
12/24/2008WO2008156816A2 Renin inhibitors
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008155890A1 Method for producing glycoside aglycone
12/24/2008WO2008055870A8 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
12/24/2008CN101328160A Preparation of xylose glycal
12/24/2008CN101328135A Carbonyl phenyl propanoic acid derivative compounds
12/24/2008CN100445279C Reclaiming and processing method for solvent in maltol production and device thereof
12/24/2008CN100445278C Method of synthesizing dehydro sodium acetate
12/24/2008CN100444839C Treatment of chemokine mediated diseases
12/23/2008US7468388 Using 5-aceylamino-4-azido-4-nitrophenoxycarbonyloyl) -(2-oxo (1,3-dioxolan-4-yl)-5,6-dihydropyran-2-carxylic acid methyl ester; therapy for myxovirus infections; active materials; stability; long time in lungs
12/18/2008US20080312462 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
12/18/2008US20080312186 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
12/11/2008US20080306287 Process for Preparing Tetrahydropyran-4-Carboxylic Acid Compound
12/11/2008US20080306259 Hydroxylation of beta-dicarbonyls with zirconium catalysts
12/11/2008US20080306144 Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/10/2008CN100441588C New C-glycoside derivation and its titivating use
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/02/2008US7459569 Reacting maltol or ethyl maltol with a ferric salt of citric acid, isocitric acid, succinic acid, fumaric acid, maleic acid, malonic acid, aconitic acid, glutaric acid, tartaric acid, gluconic acid, or lactic acid in an aqueous solution containing alkali metal hydroxide or sodium or potassium carbonate
12/02/2008US7459414 Herbicides
12/02/2008CA2394230C Novel stromelysin inhibitors
11/2008
11/27/2008WO2008142155A2 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexoses derivatives and new c-6 phosphorylated d-aldohexoses derivatives
11/27/2008WO2007128899A8 Stable c-glycoside sugar and c-glycoconjugate mimetics, method for preparing same and uses thereof in particular in cosmetics and drugs
11/26/2008EP1995323A1 Method for preparing C-6 phosphorylated D-aldohexoses and C-6 phosphorylated D-aldohexose derivatives
11/26/2008CN100436438C 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
11/25/2008US7456218 3-(4-{[4'-(benzyloxy)-2',6'-dimethylbiphenyl-3-yl]methoxy}-2-fluorophenyl)propanoic acid; superior GPR40 receptor function modulating action, can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes
11/20/2008WO2008141234A2 Methods of making epothilones
11/20/2008WO2008140842A1 Methods and compositions for heavy metal detoxification
11/19/2008EP1992650A1 Tertiary alcohol derivative, polymer compound and photoresist composition
11/19/2008CN101309909A 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
11/13/2008US20080281101 Hydroxylation a tetrahydropyran compound, oxidation, coupling to a 2-aminopyrimidine copound; decyclization
11/12/2008EP1989191A1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
11/12/2008EP1732912B1 An improved method for manufacture of 4-hydroxy pyran-2-one derivatives
11/12/2008EP1644340B1 N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008CN101304966A Organic compounds
11/12/2008CN100432038C Method for producing nitrile compound, carboxylic acid compound or carboxylate compound
11/05/2008EP1987015A2 Benzoyl-substituted alanines
11/05/2008CN101298448A Synthetic method of 2-benzyloxy-3-ethyl-4-methyl-5-chloro-6-[(tetrahydro-2H-pyrrole-2-oxyl)methyl ] phenol
11/05/2008CN101298447A Synthetic method of 2-benzyloxy-3-ethyl-4-methyl-5- chloro-6-[( tetrahydro-2H-pyrrole-2-oxyl)methyl] phenol
11/05/2008CN100430405C Processes for preparing calcium salt forms of statins
11/04/2008US7446196 Leptomycin compounds
10/2008
10/30/2008WO2008130508A1 Indanone derivatives that inhibit prolyl hydroxylase
10/30/2008US20080269508 from the corresponding 3,5-dihydroxy pentanoic acid derivative; in the absence or presence of orthophosphoric acid or its alkali dihydrogen salts or alkali hydrogen salts of a dibasic acid, followed by optional neutralization of the reaction mixture with an organic base
10/29/2008CN101296916A Dihydroxyanthraquinones and their use
10/28/2008US7442839 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant
10/28/2008CA2359027C S-nitrosothiols as agents for the treatment of circulatory dysfunctions
10/28/2008CA2300319C 4-cyano-4-deformylsordaricin derivatives
10/23/2008WO2008126943A2 Method for manufacturing neuraminic acid derivatives
10/23/2008WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008US20080260971 Liquid-Crystalline Medium and Liquid-Crystal Display Comprising 1,2-Difluoroethene Compounds
10/23/2008CA2783587A1 Method for manufacturing neuraminic acid derivatives
10/23/2008CA2683065A1 Method for manufacturing neuraminic acid derivatives
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/22/2008EP1981859A2 Preparation of delmopinol
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008CN101291930A Tricyclo substituted amides
10/22/2008CN101291921A Spiro [3.3] heptyl-dioxan derivatives and their use in liquid crystal media
10/22/2008CN101289440A Polyene macrocyclic compounds, preparation thereof and applications
10/22/2008CN101289439A Process for preparing arabglycal
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1641771B1 Hydroxamate sulfonamides as cd23 shedding inhibitors
10/15/2008CN100425602C Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these
10/14/2008US7435603 Labeling proteins with dyes that are insoluble or only sparingly soluble in water
10/14/2008CA2494177C Azulene derivatives and salts thereof for use as na+-glucose cotransporter inhibitors
10/09/2008WO2008120712A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 129